# Intraoperative Dexamethasone and Its Effect on Hyperglycemia

> **NCT03646916** · PHASE4 · WITHDRAWN · sponsor: **Ascension Health**

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Dexamethasone
- **OTHER:** No dexamethasone

## Key facts

- **NCT ID:** NCT03646916
- **Lead sponsor:** Ascension Health
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-09-15
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of patients
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03646916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03646916, "Intraoperative Dexamethasone and Its Effect on Hyperglycemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03646916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*